Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Reducing PM-associated CV Health Effects for Seniors

20. oktober 2020 opdateret af: Masako Morishita, Michigan State University

Reducing Particulate Matter-associated Cardiovascular Health Effects for Seniors

The objective of this study is to investigate the effectiveness of air filtration at reducing personal-level exposures to fine particulate matter (PM2.5) and mitigating related cardiovascular (CV) health effects among older adults in a residential facility in a representative US urban location.

We enrolled 40 nonsmoking older adults into a randomized double-blind crossover intervention study with daily CV health outcomes and PM2.5 exposure measurements. The study was conducted in a low-income senior living apartment building in downtown Detroit, Michigan.

Participants were exposed to three 3-day scenarios separated by one-week washout periods: unfiltered ambient air (control), low-efficiency (LE) "HEPA-type", and high-efficiency (HE) "true-HEPA" filtered air using air filtration systems in the bedroom and main living space of each residence.

The primary outcome was brachial blood pressure (BP). Secondary outcomes included noninvasive aortic hemodynamics and pulse wave velocity and heart rate variability. PM2.5 exposures were measured in the participants' residences as well as by personal-level monitoring.

Studieoversigt

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

40

Fase

  • Ikke anvendelig

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

50 år til 85 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • 50 to 85 years old
  • non-smoking healthy adults

Exclusion Criteria:

  • smoke or anyone in your residence smokes.
  • had a cardiovascular event within the past 6 months (such as myocardial infarction (heart attack), angina, cardiac or carotid surgery or stent, diagnosed peripheral arterial disease, aortic aneurysms, treated heart failure, any treated arrhythmia including atrial fibrillation)
  • have renal disease requiring dialysis.
  • have had medication changes in the past 6 weeks.
  • use supplementary oxygen.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Grundvidenskab
  • Tildeling: Randomiseret
  • Interventionel model: Crossover opgave
  • Maskning: Dobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Sham-komparator: Sham
Participants were exposed to unfiltered ambient air (sham) filtered air using air filtration systems in the bedroom and main living space of each residence.
Subjects were exposed to unfiltered air.
Aktiv komparator: Low efficiency
Participants were exposed to low-efficiency (LE) "HEPA-type" filtered air using air filtration systems in the bedroom and main living space of each residence.
Subjects were exposed to low-efficiency filtered air.
Aktiv komparator: High efficiency
Participants were exposed to high-efficiency (HE) "true-HEPA" filtered air using air filtration systems in the bedroom and main living space of each residence.
Subjects were exposed to high-efficiency filtered air.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
brachial blood pressure
Tidsramme: at the same time between 8-10 AM on 3 consecutive days starting 24 hours after filter system placement
Brachial blood pressure was measured using a BPTru device.
at the same time between 8-10 AM on 3 consecutive days starting 24 hours after filter system placement

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
noninvasive aortic hemodynamics
Tidsramme: at the same time between 8-10 AM on 3 consecutive days starting 24 hours after filter system placement
Aortic hemodynamics was measured using a SphygmoCor device.
at the same time between 8-10 AM on 3 consecutive days starting 24 hours after filter system placement
Pulse wave velocity
Tidsramme: at the same time between 8-10 AM on 3 consecutive days starting 24 hours after filter system placement
Pulse wave velocity was measured using a SphygmoCor device.
at the same time between 8-10 AM on 3 consecutive days starting 24 hours after filter system placement
heart rate variability
Tidsramme: at the same time between 8-10 AM on 3 consecutive days starting 24 hours after filter system placement
Heart rate variability was measured using a SphygmoCor device.
at the same time between 8-10 AM on 3 consecutive days starting 24 hours after filter system placement
microvasculature tone
Tidsramme: at the same time between 8-10 AM on 3 consecutive days starting 24 hours after filter system placement
Retinal photography was used to measure retinal arteriole diameters.
at the same time between 8-10 AM on 3 consecutive days starting 24 hours after filter system placement

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

21. oktober 2014

Primær færdiggørelse (Faktiske)

4. november 2016

Studieafslutning (Faktiske)

4. november 2016

Datoer for studieregistrering

Først indsendt

3. november 2017

Først indsendt, der opfyldte QC-kriterier

3. november 2017

Først opslået (Faktiske)

7. november 2017

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

22. oktober 2020

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

20. oktober 2020

Sidst verificeret

1. oktober 2020

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • R01NR014484 (U.S. NIH-bevilling/kontrakt)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Air filtration systems without filters (sham)

Abonner